These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1071637)

  • 41. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies.
    Sheppard K; Funder JW
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E224-9. PubMed ID: 3030124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deoxycorticosterone and aldosterone clearance and binding in normal and hypertensive man.
    Zipser RD; LeBoff M; Meidar V; Duke R; Horton R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1085-8. PubMed ID: 7419684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
    Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
    J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The characteristics of renal mineralocorticoid receptors in glycyrrhizinic acid or deoxycorticosterone-induced hypertensive rats.
    Hayashi T; Nakai T; Uchida K; Morimoto S; Takeda R
    Clin Exp Hypertens A; 1984; 6(9):1625-40. PubMed ID: 6239715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of plasma ACTH and adrenocortical hormones to potassium loading in essential hypertension.
    Ueda Y; Honda M; Tsuchiya M; Watanabe H; Izumi Y; Shiratsuchi T; Inoue T; Hatano M
    Jpn Circ J; 1982 Apr; 46(4):317-22. PubMed ID: 6283190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
    Ganguly A; Meikle AW; Tyler FH; West CD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ACTH on plasma levels of adrenal steroids in essential hypertension.
    Honda M
    Endocrinol Jpn; 1976 Jun; 23(3):195-202. PubMed ID: 186257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mineralcorticoid receptors along the nephron: [3H]aldosterone binding in rabbit tubules.
    Doucet A; Katz AI
    Am J Physiol; 1981 Dec; 241(6):F605-11. PubMed ID: 6275714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of steroid receptors in the gut and kidney of the frog (Rana catesbeiana) and in the gut of the turtle (Chrysemys picta).
    Mehi AZ; DiBattista JA; Sandor T
    J Steroid Biochem; 1987 May; 26(5):627-39. PubMed ID: 3035288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 54. 19-nor analogs of adrenal steroids: mineralocorticoid and glucocorticoid receptor activity.
    Wynne KN; Mercer J; Stockigt JR; Funder JW
    Endocrinology; 1980 Nov; 107(5):1278-80. PubMed ID: 6253261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corticosterone methyloxidase II activity during hemodialysis.
    Zager PG; Spalding CT; Frey HJ; Brittenham MC
    J Lab Clin Med; 1987 Feb; 109(2):178-83. PubMed ID: 3543178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia.
    Kuhnle U; Land M; Ulick S
    J Clin Endocrinol Metab; 1986 May; 62(5):934-40. PubMed ID: 3007560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two cases of low-renin hypertension thought to be due to excessive secretion of unknown mineralocorticoid.
    Haruyama K; Yamazaki M; Toki T; Fukuchi S
    Jpn Circ J; 1982 Feb; 46(2):156-61. PubMed ID: 6276583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC; Dale SL
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
    Saito I; Saruta T; Nakamura R; Misumi J; Kondo K; Matsuki S
    Jpn Circ J; 1976 Aug; 40(8):911-9. PubMed ID: 184308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of synthetic progestagens with renal mineralocorticoid receptors.
    Wambach G; Higgins JR; Kem DC; Kaufmann W
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):560-7. PubMed ID: 574701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.